サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ノロウイルス診断の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別
市場調査レポート
商品コード
1394141

ノロウイルス診断の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別

Norovirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 245 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
ノロウイルス診断の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、技術別、グレード別、用途別、エンドユーザー別、地域別
出版日: 2023年12月05日
発行: Fairfield Market Research
ページ情報: 英文 245 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のノロウイルス診断の市場規模は、2024年から2031年の間に8.7%の年間平均成長率（CAGR）で急増し、2031年には1億3,000万米ドルに達すると予測されています。2024年の市場規模は7,000万米ドルであり、現在の上昇基調を反映しています。

この顕著な成長の主な促進要因の1つは、ノロウイルス疾患の発生率の上昇です。この分野の主要参入企業やメーカーは、この感染力の強い胃腸ウイルスと闘うために洗練された技術を採用しています。その結果、医療機器メーカーは、より高感度で効率的な高度診断ツールを開発するために研究開発（R&D）投資を増やしています。このような技術革新への取り組みは、近い将来、ノロウイルス診断市場の拡大に拍車をかけると予想されます。

診断ラボの急増も市場の成長に寄与しており、メーカーの売上や収益に好影響をもたらしています。このような診断ラボの出現が続くにつれ、ノロウイルス診断市場は大きな恩恵を受けることになると思われます。

しかし、有望な成長見通しにもかかわらず、ノロウイルス診断市場に影響を及ぼす特定の障害も存在します。低所得国におけるノロウイルス感染の流行や、ノロウイルス感染に先行する症状についての認識不足などの要因が、市場の拡大を妨げています。

ノロウイルスの過小診断は、患者の健康に影響を与えるもう1つの問題であり、個人が病気に関連するスティグマやその症状についての理解不足のために医療機関を受診しない可能性があります。けいれん、吐き気、嘔吐、下痢、微熱などのノロウイルス感染の症状は、他の病気と混同されやすく、誤診や放置につながる可能性があります。このような課題に対処するためには、ノロウイルスとその診断法に関する一般市民の認識を高め、教育する努力が必要です。

米国は、ノロウイルス感染の有病率が高いことから、ノロウイルス診断市場で大きなシェアを占めています。大手企業の存在と研究開発投資の増加がこの市場の成長に寄与しています。さらに、ヘルスケアシステムと規制能力の強化を目的とした政府の取り組みが、市場拡大をさらに促進すると期待されています。

当レポートでは、世界のノロウイルス診断市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界のノロウイルス診断市場の見通し、2018年～2031年

  • 世界のノロウイルス診断市場の見通し、製品別、金額別（100万米ドル）、2018年～2031年
  • 世界のノロウイルス診断市場の見通し、エンドユーザー別、金額（100万米ドル）、2018年～2031年
  • 世界のノロウイルス診断市場の見通し、地域別、金額（100万米ドル）、2018年～2031年

第4章 北米のノロウイルス診断市場の見通し、2018年～2031年

第5章 欧州のノロウイルス診断市場の見通し、2018年～2031年

第6章 アジア太平洋のノロウイルス診断市場の見通し、2018年～2031年

第7章 ラテンアメリカのノロウイルス診断市場の見通し、2018年～2031年

第8章 中東・アフリカのノロウイルス診断市場の見通し、2018年～2031年

第9章 競合情勢

  • メーカーとエンドユーザー別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • R-Biopharm AG
    • ELITechGroup AG
    • Danaher Corporation (Cepheid)
    • Meridian Bioscience Inc.
    • Eiken Chemical Co.
    • Altona Diagnostics GmbH
    • Elisabeth Pharmacon, Spol. S Ro
    • CerTest Biotec S.L
    • Altona Diagnostics GmbH

第10章 付録

目次

The global Norovirus Diagnostics Market is set to witness substantial growth, with the market projected to surge at a Compound Annual Growth Rate (CAGR) of 8.7% between 2024 and 2031, reaching an estimated valuation of US$ 130.0 Mn by the end of the forecast period. In 2024, the market stood at a value of US$ 70 Mn, reflecting its current upward trajectory.

Rising Incidence of Norovirus Disease

One of the key driving factors behind this remarkable growth is the escalating incidence of norovirus disease. Leading participants and manufacturers in the field are adopting sophisticated techniques to combat this highly contagious stomach and intestinal virus. As a result, medical device companies have increased their Research and Development (R&D) investments to develop advanced diagnostic tools that are more sensitive and efficient. This commitment to innovation is expected to fuel the expansion of the Norovirus Diagnostics Market in the near future.

The proliferation of diagnostics laboratories is also contributing to the market's growth, bringing about favorable effects on sales and revenue for manufacturers. As these diagnostics labs continue to emerge, the market for norovirus diagnostics is set to benefit significantly.

Lack of Awareness about Norovirus

However, despite the promising growth prospects, there are certain impediments affecting the Norovirus Diagnostics Market. Factors such as the prevalence of norovirus infection in low-income nations and the lack of awareness about the symptoms preceding norovirus infection have hindered the market's expansion.

The underdiagnosis of norovirus is another issue impacting patient health, as individuals may not seek medical attention due to the stigma associated with the disease or a lack of understanding about its symptoms. The symptoms of norovirus infection, including cramps, nausea, vomiting, diarrhea, and low-grade fever, can be easily confused with other illnesses, leading to misdiagnosis or neglect. To address these challenges, efforts are needed to raise awareness and educate the public about norovirus and its diagnostic options.

Booming U.S. Market

The United States holds a significant share of the Norovirus Diagnostics Market due to the high prevalence of norovirus infections in the country. The presence of major companies and increased R&D investments have contributed to the growth of this market. Additionally, government initiatives aimed at strengthening healthcare systems and regulatory capacities are expected to further propel market expansion.

Lucrative Prospects in Germany's Medical Wellness Market

In Germany, the medical wellness market is thriving, primarily driven by the country's strong emphasis on fitness and well-being. Major players in the industry are collaborating to develop new products, enhancing the market's growth potential.

China Emerges as a Prominent Market for Medical Wellness

China is becoming a prominent market for medical wellness, with manufacturers focusing on expanding their global presence, expertise, and technological capabilities. This strategic approach is making norovirus diagnostics products more widely accessible in the Chinese market.

Competitive Landscape Analysis

The introduction and approval of innovative products are central elements of these manufacturers' strategies to enhance their market presence.

Key Companies Profiled:

  • Abbott
  • R-Biopharm AG
  • ELITechGroup AG
  • Danaher Corporation (Cepheid)
  • Meridian Bioscience Inc.
  • Eiken Chemical Co.
  • Altona Diagnostics GmbH
  • CerTest Biotec S.L
  • Elisabeth Pharmacon, Spol. S Ro
  • Qiagen
  • Altona Diagnostics GmbH
  • Eiken Chemical Co

With the global norovirus diagnostic market on a steady growth trajectory, these developments and trends highlight the promising future of diagnostics for norovirus infection, offering hope for more accurate and timely detection and treatment.

Key Segments Covered in Norovirus Diagnostics Industry Research

By Product

  • Rapid Test Kits
  • PCR Kits
  • ELISA based kits

By End-User

  • Hospitals
  • Diagnostics Labs
  • Clinics

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Norovirus Diagnostics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Norovirus Diagnostics Market Outlook, 2018 - 2031

  • 3.1. Global Norovirus Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Rapid Test Kits
      • 3.1.1.2. PCR Kits
      • 3.1.1.3. ELISA based kits
  • 3.2. Global Norovirus Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Diagnostics Labs
      • 3.2.1.3. Clinics
  • 3.3. Global Norovirus Diagnostics Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Norovirus Diagnostics Market Outlook, 2018 - 2031

  • 4.1. North America Norovirus Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Rapid Test Kits
      • 4.1.1.2. PCR Kits
      • 4.1.1.3. ELISA based kits
  • 4.2. North America Norovirus Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Diagnostics Labs
      • 4.2.1.3. Clinics
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Norovirus Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Norovirus Diagnostics Market Outlook, 2018 - 2031

  • 5.1. Europe Norovirus Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Rapid Test Kits
      • 5.1.1.2. PCR Kits
      • 5.1.1.3. ELISA based kits
  • 5.2. Europe Norovirus Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Diagnostics Labs
      • 5.2.1.3. Clinics
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Norovirus Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Norovirus Diagnostics Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Norovirus Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Rapid Test Kits
      • 6.1.1.2. PCR Kits
      • 6.1.1.3. ELISA based kits
  • 6.2. Asia Pacific Norovirus Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Diagnostics Labs
      • 6.2.1.3. Clinics
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Norovirus Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Norovirus Diagnostics Market Outlook, 2018 - 2031

  • 7.1. Latin America Norovirus Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Rapid Test Kits
      • 7.1.1.2. PCR Kits
      • 7.1.1.3. ELISA based kits
  • 7.2. Latin America Norovirus Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Diagnostics Labs
      • 7.2.1.3. Clinics
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Norovirus Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Norovirus Diagnostics Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Norovirus Diagnostics Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Rapid Test Kits
      • 8.1.1.2. PCR Kits
      • 8.1.1.3. ELISA based kits
  • 8.2. Middle East & Africa Norovirus Diagnostics Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Diagnostics Labs
      • 8.2.1.3. Clinics
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Norovirus Diagnostics Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Norovirus Diagnostics Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Norovirus Diagnostics Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. R-Biopharm AG
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. ELITechGroup AG
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Danaher Corporation (Cepheid)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Meridian Bioscience Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Eiken Chemical Co.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Altona Diagnostics GmbH
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Elisabeth Pharmacon, Spol. S Ro
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. CerTest Biotec S.L
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Altona Diagnostics GmbH
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations